AORT ARTIVION, INC.

NYSE artivion.com


$ 40.58 $ 0.39 (0.96 %)    

Tuesday, 14-Oct-2025 17:00:53 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 41.02
$ 40.24
$ 40.53 x 120
$ 42.55 x 2
$ 40.24 - $ 41.26
$ 21.97 - $ 45.07
253,032
na
1.94B
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 07-30-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-23-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-19-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 10-31-2017 09-30-2017 10-Q
33 07-25-2017 06-30-2017 10-Q
34 04-27-2017 03-31-2017 10-Q
35 02-16-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 07-26-2016 06-30-2016 10-Q
38 04-29-2016 03-31-2016 10-Q
39 02-16-2016 12-31-2015 10-K
40 10-27-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-maintains-market-outperform-on-artivion-raises-price-target-to-47

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...

 artivion-to-acquire-1300-east-anderson-lane-property-for-1205m-and-1200-east-anderson-lane-property-for-845m

On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having s...

 stifel-maintains-buy-on-artivion-raises-price-target-to-46

Stifel analyst Rick Wise maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $40 to $46.

 beyond-the-numbers-7-analysts-discuss-artivion-stock

Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinion...

 canaccord-genuity-maintains-buy-on-artivion-raises-price-target-to-50

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $41 t...

 needham-maintains-buy-on-artivion-raises-price-target-to-50

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.

 ladenburg-thalmann-downgrades-artivion-to-neutral-raises-price-target-to-388

Ladenburg Thalmann analyst Jeff Cohen downgrades Artivion (NYSE:AORT) from Buy to Neutral and raises the price target from $...

 artivion-appoints-lance-a-berry-the-companys-current-executive-vice-president-cfo-and-treasurer-as-chief-operating-officer-effective-as-of-august-11-2025

-SEC Filing

 canaccord-genuity-maintains-buy-on-artivion-raises-price-target-to-41

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $35 to...

 jmp-securities-maintains-market-outperform-on-artivion-raises-price-target-to-42

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...

 stifel-maintains-buy-on-artivion-raises-price-target-to-40

Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $36 to $40.

 needham-maintains-buy-on-artivion-raises-price-target-to-45

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $32 to $45.

 artivion-raises-fy2025-sales-guidance-from-42300m-43500m-to-43500m-44300m-vs-42740m-est

Artivion (NYSE:AORT) raises FY2025 sales outlook from $423.00 million-$435.00 million to $435.00 million-$443.00 million vs $42...

 artivion-q2-adj-eps-024-beats-000-estimate-sales-11297m-beat-10796m-estimate

Artivion (NYSE:AORT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.00) by 610...

 canaccord-genuity-initiates-coverage-on-artivion-with-buy-rating-announces-price-target-of-35

Canaccord Genuity analyst William Plovanic initiates coverage on Artivion (NYSE:AORT) with a Buy rating and announces Price ...

 artivion-enters-into-separate-privately-negotiated-exchange-agreements-with-certain-holders-of-4250-convertible-senior-notes-due-2025

Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION